Pyxis Oncology: HC Wainwright Raises PT to $7, Maintains Buy Rating

martes, 24 de marzo de 2026, 7:16 am ET1 min de lectura
PYXS--

Pyxis Oncology: HC Wainwright Raises PT to $7, Maintains Buy Rating

Pyxis Oncology: HC Wainwright Raises PT to $7, Maintains Buy Rating

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios